t807
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Sep 27, 2018 (NCT03969732)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Microtubule-associated protein tauBINDING AGENT
MAPT binding agent
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04604587 | Phase 3 | Oct 8, 2020 | National Taiwan University |
| NCT03969732 | Phase 3 | Sep 27, 2018 | National Taiwan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Taiwan University | Academic/Hospital | 2 | 2 | 1 | 2018 |
1 organizations
Page 1 / 1